Literature DB >> 11796824

Molecular interactions and functional interference between vitronectin and transforming growth factor-beta.

Michael Schoppet1, Triantafyllos Chavakis, Nadia Al-Fakhri, Sandip M Kanse, Klaus T Preissner.   

Abstract

Different extracellular matrix proteins have been described as binding proteins for growth factors, influencing their storage or presentation towards cellular receptors. The multifunctional adhesive glycoprotein vitronectin (VN), which is found in the circulation and widely distributed throughout different tissues, has been implicated in the regulation of vascular cell functions, and these activities could be related to interactions with various growth factors. In vitro, soluble VN interfered with transforming growth factor-beta (TGF-beta) binding to isolated extracellular matrix and was found to associate with TGF-beta1 and TGF-beta2 as well as with other growth factors such as vascular endothelial growth factor, epidermal growth factor, or basic fibroblast growth factor in a saturable manner. In particular, binding of TGF-beta was maximal for the heparin-binding multimeric isoform of VN, whereas VN in a ternary complex with thrombin and antithrombin or plasma VN exhibited weaker binding. Plasminogen activator inhibitor-1 (PAI-1) or heparin, but not desulfated glycosaminoglycans, interfered with binding of VN to TGF-beta, and soluble PAI-1 was able to dissociate VN-bound TGF-beta. Upon limited plasmin proteolysis of VN, only the fragments comprising the intact aminoterminal portion of VN bound to TGF-beta as did a synthetic peptide (amino acids 43 to 62), indicating that TGF-beta and PAI-1 share common binding site(s) on VN. Although VN did not influence TGF-beta bioactivity for mink lung epithelial cells, TGF-beta dose dependently inhibited both urokinase-receptor as well as alpha(v)-integrin-dependent adhesion to VN. This activity of TGF-beta was reminiscent of the antiadhesive function of PAI-1. In atherosclerotic tissue sections, staining patterns of VN and TGF-beta indicated their colocalization. These findings describe VN as a new binding protein for TGF-beta, whereby specific functions of both factors become modulated by this interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796824     DOI: 10.1038/labinvest.3780393

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Enhanced endothelialization on surface modified poly(L-lactic acid) substrates.

Authors:  Hao Xu; Rajendrasing Deshmukh; Richard Timmons; Kytai Truong Nguyen
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

3.  Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream.

Authors:  Dianzhong Zhang; Amber E Hudson; Catherine F Delostrinos; Nicole Carmean; Rocky Eastman; Bryson Hicks; Robert E Hurst; James A Bassuk
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

4.  Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.

Authors:  Mikaël M Martino; Priscilla S Briquez; Adrian Ranga; Matthias P Lutolf; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

5.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

6.  A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

Authors:  Yufeng Huang; Masashi Haraguchi; Daniel A Lawrence; Wayne A Border; Ling Yu; Nancy A Noble
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 7.  Mechanical Forces Reshape Differentiation Cues That Guide Cardiomyogenesis.

Authors:  Cassandra L Happe; Adam J Engler
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

Review 8.  Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration.

Authors:  Zhao Wei; Eugenia Volkova; Michael R Blatchley; Sharon Gerecht
Journal:  Adv Drug Deliv Rev       Date:  2019-08-14       Impact factor: 15.470

9.  Proteomic and genomic analysis of acid dentin lysate with focus on TGF-β signaling.

Authors:  Jila Nasirzade; Zahra Kargarpour; Goran Mitulović; Franz Josef Strauss; Layla Panahipour; Frank Schwarz; Reinhard Gruber
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

10.  Effect of vitronectin bound to insulin-like growth factor-I and insulin-like growth factor binding protein-3 on porcine enamel organ-derived epithelial cells.

Authors:  Yoshinori Shinohara; Shuhei Tsuchiya; Kazuo Hatae; Masaki J Honda
Journal:  Int J Dent       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.